Toxicological assessment of gadolinium release from contrast media
- 1 April 2007
- journal article
- Published by Elsevier in Experimental and Toxicologic Pathology
- Vol. 58 (5) , 323-330
- https://doi.org/10.1016/j.etp.2006.09.003
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Magnetic Resonance Contrast Agents: From the Bench to the PatientCurrent Pharmaceutical Design, 2005
- Contrast Agents for Magnetic Resonance ImagingTopics in Magnetic Resonance Imaging, 2003
- Occurrence of adverse reactions to gadolinium-based contrast material and management of patients at increased risk: A survey of the American society of neuroradiology fellowship directorsAcademic Radiology, 1999
- Gadobenate Dimeglumine 0.5 M Solution for Injection (MultiHance®): Pharmaceutical Formulation and Physicochemical Properties of a New Magnetic Resonance Imaging Contrast MediumJournal of Computer Assisted Tomography, 1999
- Toxicological Safety Evaluation of Gadobenate Dimeglumine 0.5 M Solution for Injection (MultiHance®), a New Magnetic Resonance Imaging Contrast MediumJournal of Computer Assisted Tomography, 1999
- Acute renal failure after arteriography with a gadolinium-based contrast agent.American Journal of Roentgenology, 1998
- Safety Review of Gadopentetate Dimeglumine Extended Clinical Experience after More Than Five Million ApplicationsInvestigative Radiology, 1994
- Preclinical Safety Assessment and Pharmacokinetics of Gadodiamide Injection, a New Magnetic Resonance Imaging Contrast AgentInvestigative Radiology, 1993
- Toxicology and Pharmacology of the LanthanidesPublished by Springer Nature ,1990
- The relationship between thermodynamics and the toxicity of gadolinium complexesMagnetic Resonance Imaging, 1990